Abstract:Metabotropic glutamate receptor (mGluR) agonists induce extensive phosphoinositide (PI) hydrolysis in astrocytes grown in a chemically defined medium with select growth factors. These astrocytes express mGluR5 transcripts, but none of the splice variants of mGluR1, thus permitting the characterization of mGluR5 in a native CNS cell without interference from mGluR1 activity. mGluR5 activation (1) was not associated with stimulation of cyclic AMP formation, (2) showed high sensitivity to the removal of extracellular versus intracellular Ca2+, (3) displayed high coupling efficiency relative to receptor density, and (4) induced PI hydrolysis that was suppressed by phorbol esters with low potency. The rank order of agonist potency was similar to that observed in mGluR1 and mGluR5 transfected cells. The phenylglycine antagonists tested were effective in blocking responses to 1-aminocyclopentane-1S,3R-dicarboxylic acid, but not to glutamate. Prolonged exposure to agonists induced a two-phase desensitization of mGluR5 function, an initial phase (completed by 1 h and plateaus for another 3 h) and a late phase (progressive decrease to approximately 30% of control levels by 24 h). Only the latter phase was associated with receptor down-regulation. Desensitization of mGluR5 function did not involve receptor internalization or phosphorylation mediated by protein kinase C or A; it was purely homologous, and reversible. Resensitization after short agonist treatment did not require prior receptor sequestration. Recovery after prolonged agonist exposure required new protein synthesis, but the restoration of function was more rapid than normalization of receptor protein levels, indicating that regulation also involves other components of the transduction system. The protracted desensitization of mGluR5 in astrocytes suggests that the functions mediated by this receptor are maintained under a variety of conditions ranging from repetitive stimulation to injury responses.

Signal Transduction Induced by Mglur 1/5

Phosphorylation of group I metabotropic glutamate receptors (mGluR1/5) in vitro and in vivo.

Molecular Recognition of Metabotropic Glutamate Receptor Type 1 (mglur1): Synergistic Understanding with Free Energy Perturbation and Linear Response Modeling

Metabotropic glutamate receptor mGluR5 in astrocytes: pharmacological properties and agonist regulation

Structural insights into the activation of metabotropic glutamate receptors

PQBP1: A New Player in Metabotropic Glutamate Receptor Signaling and Synaptic Plasticity

Metabotropic glutamate receptor 5 upregulates surface NMDA receptor expression in striatal neurons via CaMKII

Mglur5 Promotes the Differentiation of Rat Neural Progenitor Cells into Cholinergic Neurons and Activation of Extracellular Signal-Related Protein Kinases

Inducible expression and pharmacological characterization of the mouse metabotropic glutamate 5b receptor

Specific activation of mGlu2 induced IGF-1R transactivation in vitro through FAK phosphorylation

Signaling Specificity and Kinetics of the Human Metabotropic Glutamate Receptors

Involvement of Metabotropic Glutamate Receptor 5 in Cardiomyocyte Differentiation from Mouse Embryonic Stem Cells.

Group 1 Metabotropic Glutamate Receptors in Neurological and Psychiatric Diseases: Mechanisms and Prospective

Dynamics and Modulation of Metabotropic Glutamate Receptors.

Targeting the Type 5 Metabotropic Glutamate Receptor: A Potential Therapeutic Strategy for Neurodegenerative Diseases?

Glutamate-regulated Behavior, Transmitter Release, Gene Expression and Addictive Plasticity in the Striatum: Roles of Metabotropic Glutamate Receptors

Mglur7: the New Player Protecting the Central Nervous System

G-protein activation by a metabotropic glutamate receptor

Activation of mGluR5 Attenuates NMDA-Induced Neurotoxicity through Disruption of the NMDAR-PSD-95 Complex and Preservation of Mitochondrial Function in Differentiated PC12 Cells

Mglur1 and Mglur5 Synergistically Control Cholinergic Synaptic Transmission in the Thalamic Reticular Nucleus

SAR Studies on Mglu<sub>5</sub> Receptor Positive Allosteric Modulators (2003- 2013)